# RaySearch Laboratories

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/raysearchloratoriesb).

## Overview

RaySearch Laboratories is a Swedish medical technology company that develops software for radiation therapy and oncology workflows. Its portfolio includes treatment planning, oncology information, treatment control, and analytics software sold to cancer centers and hospitals worldwide through direct sales and distributor partnerships.

## Products & services

• RayStation treatment planning system (TPS)
• RayCare oncology information system (OIS)
• RayIntelligence cloud-based oncology analytics
• RayCommand treatment control system (TCS)
• License, support, and maintenance agreements
• Distributor-enabled software sales and implementation support

- **Treatment planning software** (45%) — Software used to design and optimize radiation therapy treatment plans.
- **Oncology information systems** (20%) — Workflow and patient-management software for radiation oncology departments.
- **Analytics and decision support** (10%) — Cloud-based tools for data analysis, reporting, and operational control.
- **Treatment control systems** (10%) — Software that links planning systems with treatment machines.
- **Licenses and support services** (15%) — Recurring software licenses, support, and maintenance agreements.

- RayStation treatment planning system (TPS)
- RayCare oncology information system (OIS)
- RayIntelligence cloud-based oncology analytics
- RayCommand treatment control system (TCS)
- License, support, and maintenance agreements
- Distributor-enabled software sales and implementation support

## Customers

RaySearch sells primarily to hospitals, cancer clinics, university hospitals, and healthcare networks that deliver radiation therapy. It also works with medical technology manufacturers, distributors, and research partners to integrate its software into clinical workflows and treatment machines.

- **Public hospitals and cancer centers** (primary) — Buy RayStation and RayCare to plan and manage radiation therapy for large patient volumes.
- **Private hospitals and clinics** (secondary) — Buy software to improve treatment precision, workflow efficiency, and patient throughput.
- **University hospitals and academic centers** (secondary) — Use the software for complex cases, clinical evaluation, and research collaboration.
- **Medical technology partners** (secondary) — Integrate RaySearch software with treatment machines and broader oncology systems.
- **Distributors** (secondary) — Sell and market the software in local markets where RaySearch lacks direct reach.

- Public hospitals buying planning and workflow software for radiation oncology
- Private cancer clinics seeking advanced planning and treatment control tools
- University hospitals using the software for complex clinical cases and research
- Healthcare networks standardizing oncology workflows across multiple sites
- Medical technology partners integrating RaySearch with treatment machines
- Distributors selling and supporting the software in local markets

## Geography

RaySearch is a global business with software used in more than 1,200 clinics across 51 countries. It operates through a Swedish headquarters, foreign subsidiaries, and a network of distributors, which gives it local market access but also exposes it to regulatory, currency, and political differences across regions.

- Software used in more than 1,200 clinics across 51 countries
- Swedish headquarters with offices and subsidiaries in multiple markets
- 19 distributors extend reach into additional countries
- Global customer base reduces dependence on any single market
- Local regulation and reimbursement conditions affect adoption and timing

## Strategy

RaySearch’s strategy centers on expanding its oncology software platform, deepening partnerships with treatment-machine manufacturers and clinical centers, and using AI to improve planning and workflow efficiency. It also emphasizes global commercialization through direct sales and distributors, while maintaining a scalable software model and strong product quality.

- **Broaden adoption of the oncology software platform** (medium-term) — A wider installed base supports recurring licenses, support relationships, and workflow integration.
- **Deepen strategic partnerships** (medium-term) — Integration with machine manufacturers and cancer centers improves product relevance and market access.
- **Apply AI to treatment planning and workflow** (short-term) — Automation can improve consistency, speed, and clinical utility of the software.
- **Scale global commercial execution** (short-term) — A distributed sales model helps reach more markets and adapt to local conditions.

- Expand RayStation, RayCare, RayIntelligence, and RayCommand adoption
- Strengthen partnerships with machine makers and clinical centers
- Use AI to automate segmentation and improve treatment planning
- Grow global reach through direct sales and distributors
- Maintain quality-assured development for regulated medical software

## Risks

RaySearch faces product-safety, cybersecurity, and talent-retention risks because its software is used in clinical radiation therapy and depends on specialized engineering expertise. It is also exposed to competitive pressure, political and currency volatility, and uneven healthcare spending across markets, which can affect sales timing and customer adoption.

- **Treatment errors from software defects** [critical] — The products are used in radiation therapy, where technical flaws can affect patient dose and safety.
- **Cyber breaches and IT disruptions** [high] — The company handles sensitive clinical and treatment data and depends on advanced IT systems.
- **Dependence on skilled employees** [high] — Product development requires specialized medical-technology and software expertise.
- **Competitive pressure** [high] — The market includes large established competitors investing heavily in oncology software and systems.
- **Political and market volatility** [medium] — Healthcare investment and procurement can be affected by tariffs, currency restrictions, and public budgets.

- Software defects could cause treatment errors and liability claims
- Cyberattacks or IT outages could disrupt development and customer support
- Loss of skilled engineers could slow product development and innovation
- Competition from Varian and Elekta can pressure market share and pricing
- Political, currency, and reimbursement changes can delay customer purchases

## Accounting

Revenue is recognized when performance obligations are satisfied, which can occur over time or at a point in time depending on the contract. The business also has meaningful quarter-to-quarter seasonality and fluctuating order flows, so timing of customer orders and project delivery can materially affect reported revenue and comparability.

- **Revenue recognition under customer contracts** — Can shift revenue between quarters and affect backlog/contract asset balances
- **Seasonality and lumpy order flow** — Reduces quarter-to-quarter comparability
- **Contract assets and customer receivables** — Affects working capital and credit-loss estimates
- **Parent company lease accounting** — Creates differences in operating profit and lease-related presentation

- Revenue timing depends on when performance obligations are satisfied
- Some contracts include multiple obligations and allocation judgments
- Quarterly results are affected by seasonality and lumpy order flow
- Development costs and lease accounting affect parent vs group comparability
- Customer receivables and contract assets require credit-loss and timing judgments

---

*Last updated: 2026-08-11T04:04:55.478368+00:00*